Gabriel Alizaidy, MD
About Gabriel Alizaidy, MD
Gabriel Alizaidy, MD, is a Clinical Research Scientist with a background in clinical informatics and a focus on men's health research. He holds a Doctor of Medicine degree and a Master of Science in Precision Health, and has worked at various healthcare institutions including CITYMD and Maximus.
Current Role at Maximus
Gabriel Alizaidy serves as a Clinical Research Scientist at Maximus, a position he has held since 2023. In this role, he focuses on conducting clinical research studies, contributing to advancements in medical knowledge and patient care. His responsibilities include designing studies, analyzing data, and collaborating with multidisciplinary teams to enhance research outcomes.
Previous Experience in Clinical Research
Prior to his current role, Gabriel Alizaidy worked as a Clinical Research Coordinator at UChicago Medicine from 2022 to 2023. He also served as a Clinical Research Scientist at Dow University of Health Sciences from 2015 to 2017. His experience in these positions involved managing clinical trials and ensuring compliance with research protocols.
Education and Expertise
Gabriel Alizaidy holds a Doctor of Medicine (MD) degree from Dow University of Health Sciences, which he earned from 2011 to 2017. He furthered his education by obtaining a Master of Science in Precision Health from the University of Chicago between 2022 and 2023. His academic background equips him with a strong foundation in clinical research methodologies and health sciences.
Clinical Informatics Experience
Gabriel Alizaidy worked as a Clinical Informatics Specialist at CITYMD for five months in 2021. In this role, he contributed to the integration of clinical data systems, enhancing the efficiency of healthcare delivery. His experience in informatics complements his research capabilities, allowing for a comprehensive approach to clinical studies.
Research Contributions and Focus Areas
Gabriel Alizaidy has been involved in clinical research studies focusing on testosterone and men's health. He contributed to a white paper on testosterone protocols and participated in research examining the effectiveness of enclomiphene citrate for testosterone improvement. His work aims to advance understanding and treatment options in this area of health.